Adage Capital Partners Gp, L.L.C. Iveric Bio, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $28.4 Million - $43 Million	1,084,140 Added 1372.33%	1,163,140 $45.8 Million
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $1.47 Million - $1.94 Million	79,000 New	79,000 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $5.92 Million - $11.7 Million	630,000 Added 286.36%	850,000 $15.2 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $2.55 Million - $5.29 Million	-280,000 Reduced 56.0%	220,000 $2.12 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $6.08 Million - $8.42 Million	500,000 New	500,000 $8.42 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.